Virvio

Virvio Overview

  • Status
  • Out of Business
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Out of Business

Virvio General Information

Description

Operator of a preclinical bio therapeutic company intended to design synthetic protein scaffolds. The company's products are based on the use of multiple high-performance algorithms to target epitopes that is inaccessible to traditional antibodies, enabling patients suffering from asthma, flu and neuropathic pain to avail treatment.

Contact Information

Website
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Primary Office
  • 4000 Mason Road
  • Suite 300
  • Seattle, WA 98195
  • United States
+1 (425) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Virvio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 27-Feb-2020 Completed Out of Business
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Jan-2016 $209K Completed Generating Revenue

Ready to get started?

Request a free trial